nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymorphone—CYP3A4—Thiotepa—sarcoma	0.158	0.405	CbGbCtD
Oxymorphone—CYP3A4—Mitoxantrone—sarcoma	0.0681	0.174	CbGbCtD
Oxymorphone—CYP3A4—Vincristine—sarcoma	0.0469	0.12	CbGbCtD
Oxymorphone—CYP2D6—Doxorubicin—sarcoma	0.0461	0.118	CbGbCtD
Oxymorphone—CYP3A4—Etoposide—sarcoma	0.0429	0.11	CbGbCtD
Oxymorphone—CYP3A4—Doxorubicin—sarcoma	0.0293	0.0748	CbGbCtD
Oxymorphone—Naloxone—CREB1—sarcoma	0.0265	1	CrCbGaD
Oxymorphone—Oedema—Vincristine—sarcoma	0.00173	0.00297	CcSEcCtD
Oxymorphone—Dyspepsia—Thiotepa—sarcoma	0.00171	0.00294	CcSEcCtD
Oxymorphone—Hot flush—Epirubicin—sarcoma	0.0017	0.00293	CcSEcCtD
Oxymorphone—Confusional state—Mitoxantrone—sarcoma	0.00169	0.00291	CcSEcCtD
Oxymorphone—Nervous system disorder—Vincristine—sarcoma	0.00169	0.00291	CcSEcCtD
Oxymorphone—Decreased appetite—Thiotepa—sarcoma	0.00169	0.00291	CcSEcCtD
Oxymorphone—Menopausal symptoms—Epirubicin—sarcoma	0.00169	0.0029	CcSEcCtD
Oxymorphone—Oedema—Mitoxantrone—sarcoma	0.00168	0.00289	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Thiotepa—sarcoma	0.00168	0.00289	CcSEcCtD
Oxymorphone—Decreased appetite—Dactinomycin—sarcoma	0.00168	0.00289	CcSEcCtD
Oxymorphone—Fatigue—Thiotepa—sarcoma	0.00168	0.00288	CcSEcCtD
Oxymorphone—Hyperhidrosis—Vincristine—sarcoma	0.00167	0.00287	CcSEcCtD
Oxymorphone—Fatigue—Dactinomycin—sarcoma	0.00167	0.00286	CcSEcCtD
Oxymorphone—Pain—Thiotepa—sarcoma	0.00166	0.00286	CcSEcCtD
Oxymorphone—Constipation—Thiotepa—sarcoma	0.00166	0.00286	CcSEcCtD
Oxymorphone—Shock—Mitoxantrone—sarcoma	0.00165	0.00284	CcSEcCtD
Oxymorphone—Pain—Dactinomycin—sarcoma	0.00165	0.00284	CcSEcCtD
Oxymorphone—Anorexia—Vincristine—sarcoma	0.00164	0.00283	CcSEcCtD
Oxymorphone—Tachycardia—Mitoxantrone—sarcoma	0.00164	0.00282	CcSEcCtD
Oxymorphone—Skin disorder—Mitoxantrone—sarcoma	0.00163	0.00281	CcSEcCtD
Oxymorphone—Lethargy—Epirubicin—sarcoma	0.00163	0.0028	CcSEcCtD
Oxymorphone—Hyperhidrosis—Mitoxantrone—sarcoma	0.00162	0.00279	CcSEcCtD
Oxymorphone—Hypotension—Vincristine—sarcoma	0.00161	0.00277	CcSEcCtD
Oxymorphone—Feeling abnormal—Thiotepa—sarcoma	0.0016	0.00276	CcSEcCtD
Oxymorphone—Anorexia—Mitoxantrone—sarcoma	0.0016	0.00275	CcSEcCtD
Oxymorphone—Diplopia—Epirubicin—sarcoma	0.00159	0.00274	CcSEcCtD
Oxymorphone—Feeling abnormal—Dactinomycin—sarcoma	0.00159	0.00274	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Thiotepa—sarcoma	0.00159	0.00273	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Dactinomycin—sarcoma	0.00158	0.00271	CcSEcCtD
Oxymorphone—Hot flush—Doxorubicin—sarcoma	0.00158	0.00271	CcSEcCtD
Oxymorphone—Hypotension—Mitoxantrone—sarcoma	0.00157	0.0027	CcSEcCtD
Oxymorphone—Menopausal symptoms—Doxorubicin—sarcoma	0.00156	0.00269	CcSEcCtD
Oxymorphone—Insomnia—Vincristine—sarcoma	0.00156	0.00268	CcSEcCtD
Oxymorphone—Urticaria—Thiotepa—sarcoma	0.00155	0.00266	CcSEcCtD
Oxymorphone—Vertigo—Etoposide—sarcoma	0.00154	0.00264	CcSEcCtD
Oxymorphone—Abdominal pain—Thiotepa—sarcoma	0.00154	0.00264	CcSEcCtD
Oxymorphone—Body temperature increased—Thiotepa—sarcoma	0.00154	0.00264	CcSEcCtD
Oxymorphone—Body temperature increased—Dactinomycin—sarcoma	0.00153	0.00262	CcSEcCtD
Oxymorphone—Abdominal pain—Dactinomycin—sarcoma	0.00153	0.00262	CcSEcCtD
Oxymorphone—Loss of consciousness—Etoposide—sarcoma	0.00151	0.00259	CcSEcCtD
Oxymorphone—Lethargy—Doxorubicin—sarcoma	0.00151	0.00259	CcSEcCtD
Oxymorphone—Decreased appetite—Vincristine—sarcoma	0.0015	0.00258	CcSEcCtD
Oxymorphone—Dyspnoea—Mitoxantrone—sarcoma	0.0015	0.00257	CcSEcCtD
Oxymorphone—Somnolence—Mitoxantrone—sarcoma	0.00149	0.00257	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Vincristine—sarcoma	0.00149	0.00256	CcSEcCtD
Oxymorphone—Fatigue—Vincristine—sarcoma	0.00149	0.00256	CcSEcCtD
Oxymorphone—Convulsion—Etoposide—sarcoma	0.00148	0.00255	CcSEcCtD
Oxymorphone—Dehydration—Epirubicin—sarcoma	0.00148	0.00255	CcSEcCtD
Oxymorphone—Dyspepsia—Mitoxantrone—sarcoma	0.00148	0.00254	CcSEcCtD
Oxymorphone—Hypertension—Etoposide—sarcoma	0.00148	0.00254	CcSEcCtD
Oxymorphone—Constipation—Vincristine—sarcoma	0.00148	0.00254	CcSEcCtD
Oxymorphone—Pain—Vincristine—sarcoma	0.00148	0.00254	CcSEcCtD
Oxymorphone—Diplopia—Doxorubicin—sarcoma	0.00148	0.00253	CcSEcCtD
Oxymorphone—Decreased appetite—Mitoxantrone—sarcoma	0.00146	0.00251	CcSEcCtD
Oxymorphone—Chest pain—Etoposide—sarcoma	0.00146	0.00251	CcSEcCtD
Oxymorphone—Orthostatic hypotension—Epirubicin—sarcoma	0.00146	0.0025	CcSEcCtD
Oxymorphone—Fatigue—Mitoxantrone—sarcoma	0.00145	0.00249	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00145	0.00249	CcSEcCtD
Oxymorphone—Pain—Mitoxantrone—sarcoma	0.00144	0.00247	CcSEcCtD
Oxymorphone—Constipation—Mitoxantrone—sarcoma	0.00144	0.00247	CcSEcCtD
Oxymorphone—Hypersensitivity—Thiotepa—sarcoma	0.00143	0.00246	CcSEcCtD
Oxymorphone—Hypersensitivity—Dactinomycin—sarcoma	0.00142	0.00245	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Vincristine—sarcoma	0.00141	0.00242	CcSEcCtD
Oxymorphone—Confusional state—Etoposide—sarcoma	0.00141	0.00242	CcSEcCtD
Oxymorphone—Asthenia—Thiotepa—sarcoma	0.0014	0.0024	CcSEcCtD
Oxymorphone—Abdominal distension—Epirubicin—sarcoma	0.00139	0.00238	CcSEcCtD
Oxymorphone—Asthenia—Dactinomycin—sarcoma	0.00139	0.00238	CcSEcCtD
Oxymorphone—Feeling abnormal—Mitoxantrone—sarcoma	0.00138	0.00238	CcSEcCtD
Oxymorphone—Pruritus—Thiotepa—sarcoma	0.00138	0.00237	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00137	0.00236	CcSEcCtD
Oxymorphone—Dehydration—Doxorubicin—sarcoma	0.00137	0.00236	CcSEcCtD
Oxymorphone—Tachycardia—Etoposide—sarcoma	0.00136	0.00234	CcSEcCtD
Oxymorphone—Abdominal pain—Vincristine—sarcoma	0.00136	0.00234	CcSEcCtD
Oxymorphone—Body temperature increased—Vincristine—sarcoma	0.00136	0.00234	CcSEcCtD
Oxymorphone—Skin disorder—Etoposide—sarcoma	0.00136	0.00233	CcSEcCtD
Oxymorphone—Hyperhidrosis—Etoposide—sarcoma	0.00135	0.00232	CcSEcCtD
Oxymorphone—Orthostatic hypotension—Doxorubicin—sarcoma	0.00135	0.00232	CcSEcCtD
Oxymorphone—Urticaria—Mitoxantrone—sarcoma	0.00134	0.00229	CcSEcCtD
Oxymorphone—Anorexia—Etoposide—sarcoma	0.00133	0.00229	CcSEcCtD
Oxymorphone—Diarrhoea—Thiotepa—sarcoma	0.00133	0.00229	CcSEcCtD
Oxymorphone—Abdominal pain—Mitoxantrone—sarcoma	0.00133	0.00228	CcSEcCtD
Oxymorphone—Body temperature increased—Mitoxantrone—sarcoma	0.00133	0.00228	CcSEcCtD
Oxymorphone—Diarrhoea—Dactinomycin—sarcoma	0.00132	0.00227	CcSEcCtD
Oxymorphone—Hypotension—Etoposide—sarcoma	0.00131	0.00224	CcSEcCtD
Oxymorphone—Dizziness—Thiotepa—sarcoma	0.00129	0.00221	CcSEcCtD
Oxymorphone—Abdominal distension—Doxorubicin—sarcoma	0.00128	0.00221	CcSEcCtD
Oxymorphone—Hypersensitivity—Vincristine—sarcoma	0.00127	0.00218	CcSEcCtD
Oxymorphone—Weight decreased—Epirubicin—sarcoma	0.00125	0.00214	CcSEcCtD
Oxymorphone—Dyspnoea—Etoposide—sarcoma	0.00125	0.00214	CcSEcCtD
Oxymorphone—Somnolence—Etoposide—sarcoma	0.00124	0.00214	CcSEcCtD
Oxymorphone—Hypersensitivity—Mitoxantrone—sarcoma	0.00124	0.00213	CcSEcCtD
Oxymorphone—Asthenia—Vincristine—sarcoma	0.00124	0.00213	CcSEcCtD
Oxymorphone—Vomiting—Thiotepa—sarcoma	0.00124	0.00213	CcSEcCtD
Oxymorphone—Pneumonia—Epirubicin—sarcoma	0.00124	0.00212	CcSEcCtD
Oxymorphone—Vomiting—Dactinomycin—sarcoma	0.00123	0.00211	CcSEcCtD
Oxymorphone—Dermatitis—Thiotepa—sarcoma	0.00123	0.00211	CcSEcCtD
Oxymorphone—Headache—Thiotepa—sarcoma	0.00122	0.00209	CcSEcCtD
Oxymorphone—Decreased appetite—Etoposide—sarcoma	0.00122	0.00209	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Etoposide—sarcoma	0.00121	0.00207	CcSEcCtD
Oxymorphone—Asthenia—Mitoxantrone—sarcoma	0.00121	0.00207	CcSEcCtD
Oxymorphone—Fatigue—Etoposide—sarcoma	0.00121	0.00207	CcSEcCtD
Oxymorphone—Pain—Etoposide—sarcoma	0.0012	0.00205	CcSEcCtD
Oxymorphone—Constipation—Etoposide—sarcoma	0.0012	0.00205	CcSEcCtD
Oxymorphone—Diarrhoea—Vincristine—sarcoma	0.00118	0.00203	CcSEcCtD
Oxymorphone—Nausea—Thiotepa—sarcoma	0.00116	0.00199	CcSEcCtD
Oxymorphone—Weight decreased—Doxorubicin—sarcoma	0.00115	0.00198	CcSEcCtD
Oxymorphone—Feeling abnormal—Etoposide—sarcoma	0.00115	0.00198	CcSEcCtD
Oxymorphone—Diarrhoea—Mitoxantrone—sarcoma	0.00115	0.00198	CcSEcCtD
Oxymorphone—Nausea—Dactinomycin—sarcoma	0.00115	0.00197	CcSEcCtD
Oxymorphone—Pneumonia—Doxorubicin—sarcoma	0.00114	0.00196	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Etoposide—sarcoma	0.00114	0.00196	CcSEcCtD
Oxymorphone—Dizziness—Vincristine—sarcoma	0.00114	0.00196	CcSEcCtD
Oxymorphone—Bradycardia—Epirubicin—sarcoma	0.00112	0.00193	CcSEcCtD
Oxymorphone—Urticaria—Etoposide—sarcoma	0.00111	0.00191	CcSEcCtD
Oxymorphone—Body temperature increased—Etoposide—sarcoma	0.00111	0.0019	CcSEcCtD
Oxymorphone—Abdominal pain—Etoposide—sarcoma	0.00111	0.0019	CcSEcCtD
Oxymorphone—Vomiting—Vincristine—sarcoma	0.0011	0.00189	CcSEcCtD
Oxymorphone—Urinary tract disorder—Epirubicin—sarcoma	0.00109	0.00187	CcSEcCtD
Oxymorphone—Dermatitis—Vincristine—sarcoma	0.00109	0.00187	CcSEcCtD
Oxymorphone—Urethral disorder—Epirubicin—sarcoma	0.00108	0.00186	CcSEcCtD
Oxymorphone—Headache—Vincristine—sarcoma	0.00108	0.00186	CcSEcCtD
Oxymorphone—Vomiting—Mitoxantrone—sarcoma	0.00107	0.00184	CcSEcCtD
Oxymorphone—Visual impairment—Epirubicin—sarcoma	0.00106	0.00183	CcSEcCtD
Oxymorphone—Dermatitis—Mitoxantrone—sarcoma	0.00106	0.00182	CcSEcCtD
Oxymorphone—Headache—Mitoxantrone—sarcoma	0.00105	0.00181	CcSEcCtD
Oxymorphone—Bradycardia—Doxorubicin—sarcoma	0.00104	0.00179	CcSEcCtD
Oxymorphone—Eye disorder—Epirubicin—sarcoma	0.00103	0.00177	CcSEcCtD
Oxymorphone—Hypersensitivity—Etoposide—sarcoma	0.00103	0.00177	CcSEcCtD
Oxymorphone—Nausea—Vincristine—sarcoma	0.00103	0.00176	CcSEcCtD
Oxymorphone—Cardiac disorder—Epirubicin—sarcoma	0.00102	0.00176	CcSEcCtD
Oxymorphone—Flushing—Epirubicin—sarcoma	0.00102	0.00176	CcSEcCtD
Oxymorphone—Urinary tract disorder—Doxorubicin—sarcoma	0.00101	0.00173	CcSEcCtD
Oxymorphone—Asthenia—Etoposide—sarcoma	0.001	0.00172	CcSEcCtD
Oxymorphone—Angiopathy—Epirubicin—sarcoma	0.001	0.00172	CcSEcCtD
Oxymorphone—Urethral disorder—Doxorubicin—sarcoma	0.001	0.00172	CcSEcCtD
Oxymorphone—Nausea—Mitoxantrone—sarcoma	0.000998	0.00172	CcSEcCtD
Oxymorphone—Immune system disorder—Epirubicin—sarcoma	0.000996	0.00171	CcSEcCtD
Oxymorphone—Mediastinal disorder—Epirubicin—sarcoma	0.000994	0.00171	CcSEcCtD
Oxymorphone—Pruritus—Etoposide—sarcoma	0.000989	0.0017	CcSEcCtD
Oxymorphone—Visual impairment—Doxorubicin—sarcoma	0.000983	0.00169	CcSEcCtD
Oxymorphone—Mental disorder—Epirubicin—sarcoma	0.000966	0.00166	CcSEcCtD
Oxymorphone—Malnutrition—Epirubicin—sarcoma	0.00096	0.00165	CcSEcCtD
Oxymorphone—Diarrhoea—Etoposide—sarcoma	0.000956	0.00164	CcSEcCtD
Oxymorphone—Eye disorder—Doxorubicin—sarcoma	0.000954	0.00164	CcSEcCtD
Oxymorphone—Cardiac disorder—Doxorubicin—sarcoma	0.000947	0.00163	CcSEcCtD
Oxymorphone—Flushing—Doxorubicin—sarcoma	0.000947	0.00163	CcSEcCtD
Oxymorphone—Flatulence—Epirubicin—sarcoma	0.000946	0.00163	CcSEcCtD
Oxymorphone—Tension—Epirubicin—sarcoma	0.000942	0.00162	CcSEcCtD
Oxymorphone—Nervousness—Epirubicin—sarcoma	0.000933	0.0016	CcSEcCtD
Oxymorphone—Angiopathy—Doxorubicin—sarcoma	0.000926	0.00159	CcSEcCtD
Oxymorphone—Dizziness—Etoposide—sarcoma	0.000924	0.00159	CcSEcCtD
Oxymorphone—Immune system disorder—Doxorubicin—sarcoma	0.000922	0.00158	CcSEcCtD
Oxymorphone—Mediastinal disorder—Doxorubicin—sarcoma	0.00092	0.00158	CcSEcCtD
Oxymorphone—Vision blurred—Epirubicin—sarcoma	0.000905	0.00155	CcSEcCtD
Oxymorphone—Mental disorder—Doxorubicin—sarcoma	0.000894	0.00154	CcSEcCtD
Oxymorphone—Vomiting—Etoposide—sarcoma	0.000889	0.00153	CcSEcCtD
Oxymorphone—Malnutrition—Doxorubicin—sarcoma	0.000888	0.00153	CcSEcCtD
Oxymorphone—Agitation—Epirubicin—sarcoma	0.000882	0.00152	CcSEcCtD
Oxymorphone—Dermatitis—Etoposide—sarcoma	0.000881	0.00151	CcSEcCtD
Oxymorphone—Headache—Etoposide—sarcoma	0.000876	0.0015	CcSEcCtD
Oxymorphone—Flatulence—Doxorubicin—sarcoma	0.000875	0.0015	CcSEcCtD
Oxymorphone—Tension—Doxorubicin—sarcoma	0.000872	0.0015	CcSEcCtD
Oxymorphone—Nervousness—Doxorubicin—sarcoma	0.000863	0.00148	CcSEcCtD
Oxymorphone—Vertigo—Epirubicin—sarcoma	0.000863	0.00148	CcSEcCtD
Oxymorphone—Syncope—Epirubicin—sarcoma	0.000861	0.00148	CcSEcCtD
Oxymorphone—Palpitations—Epirubicin—sarcoma	0.000848	0.00146	CcSEcCtD
Oxymorphone—Loss of consciousness—Epirubicin—sarcoma	0.000844	0.00145	CcSEcCtD
Oxymorphone—Vision blurred—Doxorubicin—sarcoma	0.000837	0.00144	CcSEcCtD
Oxymorphone—Convulsion—Epirubicin—sarcoma	0.000832	0.00143	CcSEcCtD
Oxymorphone—Nausea—Etoposide—sarcoma	0.00083	0.00143	CcSEcCtD
Oxymorphone—Hypertension—Epirubicin—sarcoma	0.000829	0.00142	CcSEcCtD
Oxymorphone—Chest pain—Epirubicin—sarcoma	0.000817	0.0014	CcSEcCtD
Oxymorphone—Agitation—Doxorubicin—sarcoma	0.000816	0.0014	CcSEcCtD
Oxymorphone—Anxiety—Epirubicin—sarcoma	0.000815	0.0014	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000812	0.00139	CcSEcCtD
Oxymorphone—Dry mouth—Epirubicin—sarcoma	0.000799	0.00137	CcSEcCtD
Oxymorphone—Vertigo—Doxorubicin—sarcoma	0.000798	0.00137	CcSEcCtD
Oxymorphone—Syncope—Doxorubicin—sarcoma	0.000797	0.00137	CcSEcCtD
Oxymorphone—Confusional state—Epirubicin—sarcoma	0.00079	0.00136	CcSEcCtD
Oxymorphone—Palpitations—Doxorubicin—sarcoma	0.000785	0.00135	CcSEcCtD
Oxymorphone—Oedema—Epirubicin—sarcoma	0.000784	0.00135	CcSEcCtD
Oxymorphone—Loss of consciousness—Doxorubicin—sarcoma	0.000781	0.00134	CcSEcCtD
Oxymorphone—Shock—Epirubicin—sarcoma	0.000771	0.00132	CcSEcCtD
Oxymorphone—Convulsion—Doxorubicin—sarcoma	0.00077	0.00132	CcSEcCtD
Oxymorphone—Nervous system disorder—Epirubicin—sarcoma	0.000768	0.00132	CcSEcCtD
Oxymorphone—Hypertension—Doxorubicin—sarcoma	0.000767	0.00132	CcSEcCtD
Oxymorphone—Tachycardia—Epirubicin—sarcoma	0.000765	0.00131	CcSEcCtD
Oxymorphone—Skin disorder—Epirubicin—sarcoma	0.000761	0.00131	CcSEcCtD
Oxymorphone—Hyperhidrosis—Epirubicin—sarcoma	0.000758	0.0013	CcSEcCtD
Oxymorphone—Chest pain—Doxorubicin—sarcoma	0.000756	0.0013	CcSEcCtD
Oxymorphone—Anxiety—Doxorubicin—sarcoma	0.000754	0.0013	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000751	0.00129	CcSEcCtD
Oxymorphone—Anorexia—Epirubicin—sarcoma	0.000747	0.00128	CcSEcCtD
Oxymorphone—Dry mouth—Doxorubicin—sarcoma	0.00074	0.00127	CcSEcCtD
Oxymorphone—Hypotension—Epirubicin—sarcoma	0.000732	0.00126	CcSEcCtD
Oxymorphone—Confusional state—Doxorubicin—sarcoma	0.000731	0.00126	CcSEcCtD
Oxymorphone—Oedema—Doxorubicin—sarcoma	0.000725	0.00125	CcSEcCtD
Oxymorphone—Shock—Doxorubicin—sarcoma	0.000713	0.00123	CcSEcCtD
Oxymorphone—Nervous system disorder—Doxorubicin—sarcoma	0.000711	0.00122	CcSEcCtD
Oxymorphone—Insomnia—Epirubicin—sarcoma	0.000709	0.00122	CcSEcCtD
Oxymorphone—Tachycardia—Doxorubicin—sarcoma	0.000708	0.00122	CcSEcCtD
Oxymorphone—Skin disorder—Doxorubicin—sarcoma	0.000704	0.00121	CcSEcCtD
Oxymorphone—Hyperhidrosis—Doxorubicin—sarcoma	0.000701	0.0012	CcSEcCtD
Oxymorphone—Dyspnoea—Epirubicin—sarcoma	0.000699	0.0012	CcSEcCtD
Oxymorphone—Somnolence—Epirubicin—sarcoma	0.000697	0.0012	CcSEcCtD
Oxymorphone—Anorexia—Doxorubicin—sarcoma	0.000691	0.00119	CcSEcCtD
Oxymorphone—Dyspepsia—Epirubicin—sarcoma	0.00069	0.00119	CcSEcCtD
Oxymorphone—Decreased appetite—Epirubicin—sarcoma	0.000681	0.00117	CcSEcCtD
Oxymorphone—Hypotension—Doxorubicin—sarcoma	0.000677	0.00116	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Epirubicin—sarcoma	0.000676	0.00116	CcSEcCtD
Oxymorphone—Fatigue—Epirubicin—sarcoma	0.000676	0.00116	CcSEcCtD
Oxymorphone—Pain—Epirubicin—sarcoma	0.00067	0.00115	CcSEcCtD
Oxymorphone—Constipation—Epirubicin—sarcoma	0.00067	0.00115	CcSEcCtD
Oxymorphone—Insomnia—Doxorubicin—sarcoma	0.000656	0.00113	CcSEcCtD
Oxymorphone—Dyspnoea—Doxorubicin—sarcoma	0.000646	0.00111	CcSEcCtD
Oxymorphone—Feeling abnormal—Epirubicin—sarcoma	0.000646	0.00111	CcSEcCtD
Oxymorphone—Somnolence—Doxorubicin—sarcoma	0.000645	0.00111	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Epirubicin—sarcoma	0.000641	0.0011	CcSEcCtD
Oxymorphone—Dyspepsia—Doxorubicin—sarcoma	0.000638	0.0011	CcSEcCtD
Oxymorphone—Decreased appetite—Doxorubicin—sarcoma	0.00063	0.00108	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000626	0.00108	CcSEcCtD
Oxymorphone—Fatigue—Doxorubicin—sarcoma	0.000625	0.00107	CcSEcCtD
Oxymorphone—Urticaria—Epirubicin—sarcoma	0.000622	0.00107	CcSEcCtD
Oxymorphone—Constipation—Doxorubicin—sarcoma	0.00062	0.00107	CcSEcCtD
Oxymorphone—Pain—Doxorubicin—sarcoma	0.00062	0.00107	CcSEcCtD
Oxymorphone—Abdominal pain—Epirubicin—sarcoma	0.000619	0.00106	CcSEcCtD
Oxymorphone—Body temperature increased—Epirubicin—sarcoma	0.000619	0.00106	CcSEcCtD
Oxymorphone—Feeling abnormal—Doxorubicin—sarcoma	0.000597	0.00103	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Doxorubicin—sarcoma	0.000593	0.00102	CcSEcCtD
Oxymorphone—Hypersensitivity—Epirubicin—sarcoma	0.000577	0.000992	CcSEcCtD
Oxymorphone—Urticaria—Doxorubicin—sarcoma	0.000576	0.00099	CcSEcCtD
Oxymorphone—Abdominal pain—Doxorubicin—sarcoma	0.000573	0.000985	CcSEcCtD
Oxymorphone—Body temperature increased—Doxorubicin—sarcoma	0.000573	0.000985	CcSEcCtD
Oxymorphone—Asthenia—Epirubicin—sarcoma	0.000562	0.000966	CcSEcCtD
Oxymorphone—Pruritus—Epirubicin—sarcoma	0.000554	0.000953	CcSEcCtD
Oxymorphone—Diarrhoea—Epirubicin—sarcoma	0.000536	0.000921	CcSEcCtD
Oxymorphone—Hypersensitivity—Doxorubicin—sarcoma	0.000534	0.000918	CcSEcCtD
Oxymorphone—Asthenia—Doxorubicin—sarcoma	0.00052	0.000894	CcSEcCtD
Oxymorphone—Dizziness—Epirubicin—sarcoma	0.000518	0.00089	CcSEcCtD
Oxymorphone—Pruritus—Doxorubicin—sarcoma	0.000513	0.000881	CcSEcCtD
Oxymorphone—Vomiting—Epirubicin—sarcoma	0.000498	0.000856	CcSEcCtD
Oxymorphone—Diarrhoea—Doxorubicin—sarcoma	0.000496	0.000852	CcSEcCtD
Oxymorphone—Dermatitis—Epirubicin—sarcoma	0.000494	0.000848	CcSEcCtD
Oxymorphone—Headache—Epirubicin—sarcoma	0.000491	0.000844	CcSEcCtD
Oxymorphone—Dizziness—Doxorubicin—sarcoma	0.000479	0.000824	CcSEcCtD
Oxymorphone—Nausea—Epirubicin—sarcoma	0.000465	0.0008	CcSEcCtD
Oxymorphone—Vomiting—Doxorubicin—sarcoma	0.000461	0.000792	CcSEcCtD
Oxymorphone—Dermatitis—Doxorubicin—sarcoma	0.000457	0.000785	CcSEcCtD
Oxymorphone—Headache—Doxorubicin—sarcoma	0.000454	0.000781	CcSEcCtD
Oxymorphone—Nausea—Doxorubicin—sarcoma	0.000431	0.00074	CcSEcCtD
